Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
life sciences
national
3
×
national blog main
national top stories
3
×
new york top stories
3
×
roche
3
×
san francisco top stories
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
drug pricing
new york blog main
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
advaxis
aimmune therapeutics
alder biopharmaceuticals
alexander hardy
andrew oxtoby
babies
billy dunn
biogen
blueprint medicines
breakup
bridge bio pharma
What
medicine
3
×
approved
drug
fda
new
atrophy
big
bio
bosley's
bosley’s
bridge
bucks
cancer
cas
ceo
crime
crispr
daily
deeper
departure
dna
editas
evrysdi
exit
fingerprint
friday
genetic
going
green
guiding
home
intended
katrine
lights
liquid
matter
moves
muscular
nd
oks
Language
unset
Current search:
national
×
medicine
×
" national top stories "
×
roche
×
" new york top stories "
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues